Record overview
Status and phase
Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2
Sponsor: City of Hope Medical Center
Condition: Plasma Cell Myeloma, Secondary Amyloidosis
NCT03346135
Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: long_recruitment_duration_signal
Results signal: Low Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
No stop reason available in the current public record.